An executive at a major pharmaceutical company launched a compound designed to protect collagen against optic nerve and liver damage.

Our client made a case to her employers for the use of this compound on the face and body. After all, she said, our skin is our largest organ. But the pharmaceutical house had no interest in pursuing the Beauty Market.

She so strongly believed its use would combat lines, wrinkles, and dark spots that the breakdown of collagen allowed that she bought out the license for Beauty. She named it Meg21 and brought it to us.  

For its positioning, we returned to Science, where Meg21 was born.

Immediately, the viewer feels the weight of understanding this is no mere cream. The compound that makes up Meg21 has been held, as one might say, to a “higher standard”.